Mario Negri Sud Foundation

Recent papers from Mario Negri Sud Foundation

1. Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial FibrillationJournal of the American College of Cardiology · 2012
2. Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)Journal of the American College of Cardiology · 2008
3. Effect of a behavioral counseling for adoption and maintenance of a physically active lifestyle on long-term mortality in people with type 2 diabetes: post hoc analysis of the Italian Diabetes and Exercise Study_2Nature Communications · 2026
4. Effect of sustained decreases in sedentary time and increases in physical activity on liver enzymes and indices in type 2 diabetesFrontiers in Endocrinology · 2024
5. Relationships of Changes in Physical Activity and Sedentary Behavior With Changes in Physical Fitness and Cardiometabolic Risk Profile in Individuals With Type 2 Diabetes: The Italian Diabetes and Exercise Study 2 (IDES_2)Diabetes Care · 2021
6. Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic FibrosisFrontiers in Pharmacology · 2021
7. let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjectsPLoS ONE · 2021
8. Type-4 phosphodiesterase (PDE4) blockade prevents NETosis in cystic fibrosis2021
9. Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the MouseInternational Journal of Molecular Sciences · 2019
10. PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver FailureScientific Reports · 2019
11. Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 DiabetesJAMA · 2019
12. Prevalence of Cardiovascular Risk Factors in Three Andean Countries: Systematic Review with Meta-Analysis 2000-2017World Journal of Cardiovascular Diseases · 2019
13. Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High‐Risk Patients for Cardiovascular DiseaseClinical Pharmacology & Therapeutics · 2018
14. Solid Lipid Nanoparticles of Albendazole for Enhancing Cellular Uptake and Cytotoxicity against U-87 MG Glioma Cell LinesMolecules · 2017
15. Hepatic peroxisome proliferator‐activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in miceHepatology · 2017
16. The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responsesJournal of Biological Chemistry · 2017
17. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumoursMolecular Cancer · 2017
18. Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancerOncotarget · 2017
19. Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in miceScientific Reports · 2016
20. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver diseaseHepatology · 2016